Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Scully

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|January 1, 1997
Unusual presentation of primary sclerosing cholangitisB C Pineau, L P Pattee, S McGuire, et al.
Journal of Hepatology|January 1, 1986
Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studiesL J Scully, A M Lever, I Yap, et al.
Journal of Hepatology|August 1, 1987
Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatmentL J Scully, R Shein, P Karayiannis, et al.
Infection|January 1, 1987
A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response ratesH C Thomas, L J Scully, A M Lever, et al.
Hepatology (Baltimore, Md.)|July 1, 1987
Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferonJ A McDonald, L Caruso, P Karayiannis, et al.
Gut|August 1, 1989
Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of responseG Chen, P Karayiannis, M J McGarvey, et al.
Nucleic Acids Research|October 20, 1998
Primer specific and mispair extension analysis (PSMEA) as a simple approach to fast genotypingY W Hu, E Balaskas, G Kessler, et al.
Hepatology (Baltimore, Md.)|May 1, 1994
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosisE J Heathcote, K Cauch-Dudek, V Walker, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?M R Kilmurry, E J Heathcote, K Cauch-Dudek, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|January 1, 1997
Unusual presentation of primary sclerosing cholangitisB C Pineau, L P Pattee, S McGuire, et al.
Journal of Hepatology|January 1, 1986
Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studiesL J Scully, A M Lever, I Yap, et al.
Journal of Hepatology|August 1, 1987
Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs. 24 weeks of thrice weekly treatmentL J Scully, R Shein, P Karayiannis, et al.
Infection|January 1, 1987
A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response ratesH C Thomas, L J Scully, A M Lever, et al.
Hepatology (Baltimore, Md.)|July 1, 1987
Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferonJ A McDonald, L Caruso, P Karayiannis, et al.
Gut|August 1, 1989
Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of responseG Chen, P Karayiannis, M J McGarvey, et al.
Nucleic Acids Research|October 20, 1998
Primer specific and mispair extension analysis (PSMEA) as a simple approach to fast genotypingY W Hu, E Balaskas, G Kessler, et al.
Hepatology (Baltimore, Md.)|May 1, 1994
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosisE J Heathcote, K Cauch-Dudek, V Walker, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?M R Kilmurry, E J Heathcote, K Cauch-Dudek, et al.
Pageof 2